Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Net Equity Issued and Repurchased (2009 - 2026)

Updated

Alnylam Pharmaceuticals' Net Equity Issued and Repurchased was $33.56 million in Q2 2026, down 58.7% from $81.22 million a year earlier but up 155.1% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Alnylam Pharmaceuticals' Net Equity Issued and Repurchased was $166.16 million through Jun 30, 2026, down 39.6% year-over-year; for FY2025, it was $250.03 million, down 17.5% from FY2024.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 4.5% (FY2020 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $302.95 million in FY2024 (+105.4%), $147.46 million in FY2023 (-43.1%), $259.36 million in FY2022 (+5.3%) and $246.27 million in FY2021 (+22.8%).
  • Quarterly Net Equity Issued and Repurchased has moved between $13.16 million (Q1 2026) and $153.02 million (Q3 2022) over five years.
  • Compared with a year earlier, Net Equity Issued and Repurchased was higher in four of the last eight quarters, with growth averaging 32.5%.
  • The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q3 2024 (growth of 335.5%); the worst was Q3 2023 (a decline of 83.8%).
  • Per Business Quant data, ALNY's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $13.16 million (Q1 2026), $41.7 million (Q4 2025) and $77.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 6.00 Mn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 9.00 Mn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 47.70 Mn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 33.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.56 Mn
Mar 31, 2026 13.16 Mn
Dec 31, 2025 41.70 Mn
Sep 30, 2025 77.74 Mn
Jun 30, 2025 81.22 Mn
Mar 31, 2025 49.37 Mn
Dec 31, 2024 36.28 Mn
Sep 30, 2024 108.04 Mn
Jun 30, 2024 132.78 Mn
Mar 31, 2024 25.86 Mn
Dec 31, 2023 30.89 Mn
Sep 30, 2023 24.81 Mn
Jun 30, 2023 49.39 Mn
Mar 31, 2023 42.37 Mn
Dec 31, 2022 56.71 Mn
Sep 30, 2022 153.02 Mn
Jun 30, 2022 22.50 Mn
Mar 31, 2022 27.12 Mn
Dec 31, 2021 45.04 Mn
Sep 30, 2021 72.39 Mn
API Access

Alnylam Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALNY&period=max&api_key=YOUR_API_KEY